Department of Neurosurgery, Hirosaki University, 5-Zaihuchou, Hirosaki, Aomori Prefecture 036-8562, Japan.
Biomed Res Int. 2014;2014:253746. doi: 10.1155/2014/253746. Epub 2014 May 11.
Cerebral vasospasm of the major cerebral arteries, which is characterized by angiographic narrowing of those vessels, had been recognized as a main contributor to delayed cerebral ischemia (DCI) in subarachnoid hemorrhage (SAH) patients. However, the CONSCIOUS-1 trial revealed that clazosentan could not improve mortality or clinical outcome in spite of successful reduction of relative risk in angiographic vasospasm. This result indicates that the pathophysiology underlying DCI is multifactorial and that other pathophysiological factors, which are independent of angiographic vasospasm, can contribute to the outcome. Recent studies have focused on microcirculatory disturbance, such as microthrombosis and arteriolar constriction, as a factor affecting cerebral ischemia after SAH. Reports detecting microthrombosis and arteriolar constriction will be reviewed, and the role of the microcirculation on cerebral ischemia during vasospasm after SAH will be discussed.
大脑主要动脉的血管痉挛,其特征是这些血管的血管造影狭窄,已被认为是蛛网膜下腔出血 (SAH) 患者迟发性脑缺血 (DCI) 的主要原因。然而,CONSCIOUS-1 试验表明,尽管血管造影血管痉挛的相对风险成功降低,但 clazosentan 不能改善死亡率或临床结局。这一结果表明,DCI 的病理生理学是多因素的,其他与血管造影血管痉挛无关的病理生理学因素也可能导致结局不佳。最近的研究集中在微循环障碍上,如微血管血栓形成和小动脉收缩,作为影响蛛网膜下腔出血后脑缺血的一个因素。将对检测微血管血栓形成和小动脉收缩的报告进行综述,并讨论在蛛网膜下腔出血后血管痉挛期间微循环对脑缺血的作用。